tradingkey.logo

DaVita Inc

DVA
查看详细走势图
153.950USD
+0.670+0.44%
交易中 美东报价延迟15分钟
28.94B总市值
15.30市盈率 TTM

DaVita Inc

153.950
+0.670+0.44%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.44%

5天

+2.65%

1月

+2.01%

6月

+15.21%

今年开始到现在

+35.51%

1年

+2.35%

查看详细走势图

TradingKey DaVita Inc股票评分

单位: USD 更新时间: 2026-03-24

操作建议

DaVita Inc当前公司基本面数据相对稳定,最新ESG披露属于行业领先水平。增长潜力很大。当前估值合理,在医疗服务供应商行业排名31/75位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价151.51。中期看,股价处于上升通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

DaVita Inc评分

相关信息

行业排名
31 / 75
全市场排名
176 / 4547
所属行业
医疗服务供应商

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
看空

DaVita Inc亮点

亮点风险
DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
估值合理
公司最新PE估值15.24,处于3年历史合理位
机构加仓
最新机构持股36.29M股,环比增加0.04%
路易斯·摩尔·贝肯持仓
明星投资者路易斯·摩尔·贝肯持仓,最新持仓市值56.35K

分析师目标

根据 10 位分析师
持有
评级
151.514
目标均价
+1.48%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

DaVita Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

DaVita Inc简介

DaVita Inc. is a healthcare provider focused on transforming care delivery to improve the quality of life for patients globally. The Company is a provider of kidney care services in the United States. Its United States dialysis (U.S. dialysis) and related lab services business treats patients with chronic kidney failure and end-stage kidney disease (ESKD). The Company’s robust platform delivers kidney care services and includes established nephrology and payor relationships. The Company’s international operations provide dialysis and administrative services to a total of outpatient dialysis centers. The Company’s U.S. integrated kidney care (IKC) business provides integrated care and disease management services to patients in risk-based integrated care arrangements and to additional patients in other integrated care arrangements across the United States. It also maintains a few other ancillary services and investments outside its U.S. dialysis, U.S. IKC, or international operations.
公司代码DVA
公司DaVita Inc
CEORodriguez (Javier J)
网址https://www.davita.com/
KeyAI